![Butanedioic acid, 2-hydroxy-, compd with7-[(3S,5S)-3-amino-5-methyl-1-piperidinyl]-1-cyclopropyl-1…](https://static.cymitquimica.com/products/3D/img/FB151626.png "Clique para ampliar")
Butanedioic acid, 2-hydroxy-, compd with7-[(3S,5S)-3-amino-5-methyl-1-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quino linecarboxylicacid
CAS: 951163-60-3
Ref. 3D-FB151626
| 1mg | Descontinuado | ||
| 5mg | Descontinuado |
Informação sobre produto
Nome:
Butanedioic acid, 2-hydroxy-, compd with7-[(3S,5S)-3-amino-5-methyl-1-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quino linecarboxylicacid
Descrição:
Butanedioic acid, 2-hydroxy-, compd with7-[(3S,5S)-3-amino-5-methyl-1-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quino linecarboxylicacid is a new antibiotic that has been shown to be active against methicillin susceptible and resistant Staphylococcus aureus. It has a pharmacokinetic study in humans, and the results show that it is excreted mainly through urine as its conjugates. In vitro studies showed that this drug is metabolized by hydrolysis of the ester linkage by esterases or glucuronidases. The major metabolite was identified as butanedioic acid with no change in the stereochemistry of the molecule. This compound also binds to human proteins and metal ions such as Cu2+, Fe2
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
505.52 g/mol
Fórmula:
C24H31N3O9
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
